Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)

NCT02647255 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT02647255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02647255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)
Lead sponsor
Peking University First Hospital
Phase
Phase 2/3
Overall status
Terminated
Start date
March 31, 2016
Completion date
October 31, 2020
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal insufficiency, glomerulonephritis, iga, kidney diseases, rapidly progressive glomerulonephritis